Conavi Medical Corp.
CNVIF
$0.26
$0.00461.80%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 54.62% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 54.62% | -- | -- | -- | |
| Cost of Revenue | -20.86% | -- | -- | -- | |
| Gross Profit | 158.33% | -- | -- | -- | |
| SG&A Expenses | 12.15% | -- | -- | -- | |
| Depreciation & Amortization | -25.91% | -- | -- | -- | |
| Other Operating Expenses | 22.43% | -- | -- | -- | |
| Total Operating Expenses | 3.57% | -- | -- | -- | |
| Operating Income | 3.61% | -- | -- | -- | |
| Income Before Tax | -32.97% | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -32.97% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -32.97% | -- | -- | -- | |
| EBIT | 3.61% | -- | -- | -- | |
| EBITDA | 2.65% | -- | -- | -- | |
| EPS Basic | -8.49% | -- | -- | -- | |
| Normalized Basic EPS | 22.54% | -- | -- | -- | |
| EPS Diluted | -8.49% | -- | -- | -- | |
| Normalized Diluted EPS | 22.54% | -- | -- | -- | |
| Average Basic Shares Outstanding | 300.91% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 300.91% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |